Signaling pathways of LIGHT induced macrophage migration and vascular smooth muscle cell proliferation

Journal of Cellular Physiology

Volumn 209, Issue 3, 2006, Pages 735-743

  Wei, Chun Yu ^a   Chou, Yin Hsiang ^a   Ho, Feng Ming ^b   Hsieh, Shie Liang ^c   Lin, Wan Wan ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYCLIN D; FOCAL ADHESION KINASE; HERPES VIRUS ENTRY MEDIATOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN BETA RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN LIGHT; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN; RETINOBLASTOMA PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL CYCLE REGULATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ATHEROSCLEROSIS; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME INHIBITORS; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

HERPESVIRIDAE;

EID: 33750507694     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20742     Document Type: Article

References (42)

1. Arcaro A, Wymann MP. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 296:297-301.
2. Barone MV, Courtneidge SA. 1995. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378:509-512.
3. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686.
4. Chang YH, Hsieh SL, Chen MC, Lin WW. 2002. Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation. Exp Cell Res 278:166-174.
5. Chen HC, Chan PC, Tang MJ, Cheng CH, Chang TJ. 1998. Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation. J Biol Chem 273:25777-25782.
6. Chen MC, Hwang MJ, Chou YC, Chen WH, Cheng G, Nakano H, Luh TY, Mai SC, Hsieh SL. 2003. The role of apoptosis signal-regulating kinase 1 in lymphotoxin-β receptor-mediated cell death. J Biol Chem 278:16073-16081.
7. Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497-508.
8. Danenberg HD, Fishbein I, Gao J, Mönkkönen J, Reich R, Gati I, Moerman E, Golomb G. 2002. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 106:599-605.
9. Duncia JV, Santella JB, Higley CA, Pitts WJ, Wityak J, Frietze WE, Rankin FW, Sun JH, Earl RA, et al. 1998. MEK inhibitors: The chemistry and biological activity of UO126, its analogs, and cyclization products. Biorg Med Chem Lett 8:2839-2844.
10. Fu YX, Chaplin DD. 1999. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 17:399-433.
11. Gallagher TF, Seibel GL, Kassis S, Laydon JT, Blumenthal MJ, Lee JC, Lee D, Boehm JC, Fier-Thompson SM, Abt WJ, et al. 1997. Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Biorg Med Chem 5:49-64.
12. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE. 1997. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension 29:334-339.
13. Granger SW, Ricket S. 2003. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev 14:289-296.
14. Gutenberg A, Bruck W, Buchfelder M, Ludwig HC. 2004. Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol 108:224-230.
15. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem 271:695-701.
16. Harrop JA, McDonnell PC, Brigham-Burke M, Lyn SD, Minton J, Tan KB, Dede K, Spampanato J, Silverman C, Hensley P, DiPrinzio R, Emery JG, Deen K, Eichman C, Chabot-Fletcher M, Truneh A, Young PR. 1998a. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 273:27548-27556.
17. Harrop JA, Reddy M, Dede K, Brigham-Burke M, Lyn S, Tan KB, Silverman C, Eichman C, DiPrinzio R, Spampanato J, Porter T, Holmes S, Young PR, Truneh A. 1998b. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF Receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol 161:1786-1794.
18. Hsu H, Solpvyev I, Colombero A, Elliott R, Kelley M, Boyle WJ. 1997. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem 272:13471-13474.
19. Hsu MJ, Lin WW, Tsao WC, Chang YC, Hsu TL, Chiu AW, Chio CC, Hsieh SL. 2004. Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3. Exp Cell Res 292:241-251.
20. Hu Y, Zou Y, Dietrich H, Wick G, Xu Q. 1999. Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 100:861-868.
21. Izumi Y, Kim S, Namba M, Yasumoto H, Miyazaki H, Hoshiga M, Kaneda Y, Morishita R, Zhan Y, Iwao H. 2001. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res 88:1120-1126.
22. Kosuge H, Suzuki JI, Kakuta T, Haraguchi G, Koga N, Futamatsu H, Gotoh R, Inobe M, Uebe T. 2004. Attenuation of graft arterial disease by manipulation of the LIGHT pathway. Arterioscler Thromb Vasc Biol 24:1-8.
23. Kwon BS, Tan KB, Ni J, On KO, Lee ZH, Kim KK, Kim YJ, Wang S, Gentz R, Yu GL. 1997. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 272:14272-14276.
24. Kyriakis JM, Avruch J. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869.
25. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL. 2001. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:14443-14450.
26. Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, Park JE. 2001. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21:2004-2010.
27. Lowell CA, Soriano P, Varmus HE. 1994. Functional overlap in the src gene family: Inactivation of hck and fgr impairs natural immunity. Genes Dev 8:387-398.
28. Marsters SA, Ayre TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A. 1997 Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 272:14029-14032.
29. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin a are ligands for herpesvirus entry mediator. Immunity 8:21-30.
30. Morel Y, Schiano de Colella JM, Harrop J, Deen KC, Holmes SD, Wattam TA, Khandekar SS. Truneh A, Sweet RW, Gastaut JA, Olive D, Costello RT. 2000. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol 165:4397-4386.
31. Pang L, Sawada T, Decker SJ, Saltiel AR. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588.
32. Puglielli MT, Browning JL, Brewer AW, Schreiber RD, Shieh WJ, Altman JD, Oldstone MB, Zaki SR, Ahmed R. 1999. Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway. Nature Med 5:1370-1374.
33. Rooney IA, Butrovich KD, Glass AA, Borboroglu S, Benedict CA, Whitbeck JC. 2000. The Lymphotoxin-β receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem 275:14307-14315.
34. Ross R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809.
35. Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K. 2002. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin β in mesenteric lymph node genesis. J Exp Med 195:1613-1624.
36. Shi G, Luo H, Wan X, Salcedo TW, Zhang J, Wu J. 2002. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100:3279-3286.
37. Tamada K, Shimozaki K, Chapoval A, Zhai Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J, Chen L. 2000a. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164:4105-4110.
38. Tamada K, Shimozaki K, Chapoval A, Zhu G, Cica G, Flies D, Boone T, Hsu H, Fu YX, Nagata S, Ni J, Chen L. 2000b. Modulation of T-cell-mediated immunity in the tumor and graft-versus-host disease models trough the LIGHT co-stimulatory pathway. Nat Med 6:283-288.
39. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331-367.
40. Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, Kwon BS. 1998. LIGHT, a novel ligand for lymphotoxin β receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 102:1142-1151.
41. Zhan Y, Kim S, Izumi Y, Izumya Y, Nakao T, Miyazaki H, Iwao H. 2003. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 23:795-801.
42. Zou GM, Hu WY. 2005. LIGHT regulates CD86 expression on dendritic cells through NF-κB, but not JNK/AP-1 signal transduction pathway. J Cell Physiol 205:437-443.